Relationship between reduced serum IGF-I levels and accumulation of visceral fat in Japanese men

被引:47
作者
Kunitomi, M
Wada, J
Takahashi, K
Tsuchiyama, Y
Mimura, Y
Hida, K
Miyatake, N
Fujii, M
Kira, S
Shikata, K
Makino, H
机构
[1] Okayama Univ, Sch Med, Dept Med 3, Okayama 7008558, Japan
[2] Okayama Univ, Fac Educ, Okayama, Japan
[3] Okayama So Inst Hlth, Okayama, Japan
[4] Okayama Univ, Sch Med, Dept Publ Hlth, Okayama 700, Japan
关键词
insulin-like growth factor-I (IGF-I); visceral fat; exercise;
D O I
10.1038/sj.ijo.0801899
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To investigate whether the changes in IGF-1 concentrations after weight reduction in Japanese overweight men are associated with changes in visceral and subcutaneous fat. DESIGN: Cross-sectional and longitudinal clinical intervention study with exercise education. SUBJECTS: One-hundred and twelve Japanese overweight men aged 30-59y (body mass index (BMI) 28.4+/-2.5 kg/m(2)) and 33 normal-weight men aged 30-39y (BMI 22.1+/-1.5 kg/m(2)) at baseline. From the participants, 56 randomly selected overweight men (BMI 28.8+/-2.8) were further enrolled into a 1 y exercise program. MEASUREMENTS: Fat distribution was evaluated by visceral fat M and subcutaneous fat (S) areas measured with computed tomography scanning at umbilical levels, metabolic parameters and hormones including insulin, leptin and IGF-1 at baseline and after 1 y. RESULTS: In 112 overweight subjects at baseline, insulin (10.5+/-5.0 muUl/ml) and leptin (6.4+/-3.7 ng/ml) significantly correlated with both V (r=0.260, P=0.0073; r=0.410, P<0.0001) and S areas (r=0.377, P<0.0001; r=0.613, P<0.0001), respectively. IGF-1 (156.8+/-48.7 muU/ml) significantly and negatively correlated with V area (r= -0.242, P=0.0125)and age (r= - 0.192, P=0.0480). In normal-weight men aged 30-39y (n=33) and age-matched subjects (n=30) selected from the 112 overweight men, the serum IGF-1 further tightly correlated with V area (r= - 0.467, P<0.0001). Visceral fat area and age were independently related to serum IGF-1 levels by multiple regression analysis. By intervention with exercise education, 56 overweight subjects showed an increase in daily steps (6224+/-2781 to 7898+/-4141 steps/day) and reduction of BMI (28.8+/-2.8 to 27.7+/-2.9). DeltaIGF-1 significantly correlated with DeltaV area (r= - 0.432, P = 0.0009) but not with DeltaS area or DeltaBMI. CONCLUSION: The present study indicated a negative correlation between IGF-1 levels and visceral fat at baseline as well as an association between the reduction in visceral fat and increase in IGF-1 levels after an exercise intervention.
引用
收藏
页码:361 / 369
页数:9
相关论文
共 39 条
[11]   HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].
GORDON, T ;
CASTELLI, WP ;
HJORTLAND, MC ;
KANNEL, WB ;
DAWBER, TR .
AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) :707-714
[12]   A prospective analysis of the HOMA model - The Mexico City Diabetes Study [J].
Haffner, SM ;
Gonzalez, C ;
Miettinen, H ;
Kennedy, E ;
Stern, MP .
DIABETES CARE, 1996, 19 (10) :1138-1141
[13]   THE DISTAL AXIS OF GROWTH-HORMONE (GH) IN NUTRITIONAL DISORDERS - GH-BINDING PROTEIN, INSULIN-LIKE GROWTH FACTOR-I (IGF-I), AND IGF-I RECEPTORS IN OBESITY AND ANOREXIA-NERVOSA [J].
HOCHBERG, Z ;
HERTZ, P ;
COLIN, V ;
ISHSHALOM, S ;
YESHURUN, D ;
YOUDIM, MBH ;
AMIT, T .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (01) :106-112
[14]   Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotropic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men [J].
Iranmanesh, A ;
South, S ;
Liem, AY ;
Clemmons, D ;
Thorner, MO ;
Weltman, A ;
Veldhuis, JD .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 139 (01) :59-71
[15]   Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure [J].
Johannsson, G ;
Marin, P ;
Lonn, L ;
Ottosson, M ;
Stenlof, K ;
Bjorntorp, P ;
Sjostrom, L ;
Bengtsson, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (03) :727-734
[16]   REGIONAL OBESITY AND RISK OF CARDIOVASCULAR-DISEASE - THE FRAMINGHAM-STUDY [J].
KANNEL, WB ;
CUPPLES, LA ;
RAMASWAMI, R ;
STOKES, J ;
KREGER, BE ;
HIGGINS, M .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1991, 44 (02) :183-190
[17]   Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects [J].
Lanzi, R ;
Luzi, L ;
Caumo, A ;
Andreotti, AC ;
Manzoni, MF ;
Malighetti, ME ;
Sereni, LP ;
Pontiroli, AE .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (09) :1152-1156
[18]   REDUCED GROWTH-HORMONE RESPONSE TO GROWTH HORMONE-RELEASING HORMONE IN CHILDREN WITH SIMPLE OBESITY - EVIDENCE FOR SOMATOMEDIN-C MEDIATED INHIBITION [J].
LOCHE, S ;
CAPPA, M ;
BORRELLI, P ;
FAEDDA, A ;
CRINO, A ;
CELLA, SG ;
CORDA, R ;
MULLER, EE ;
PINTOR, C .
CLINICAL ENDOCRINOLOGY, 1987, 27 (02) :145-153
[19]   Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients [J].
Maccario, M ;
Ramunni, J ;
Oleandri, SE ;
Procopio, M ;
Grottoli, S ;
Rossetto, R ;
Savio, P ;
Aimaretti, G ;
Camanni, F ;
Ghigo, E .
INTERNATIONAL JOURNAL OF OBESITY, 1999, 23 (06) :612-618
[20]  
MARIN P, 1993, INT J OBESITY, V17, P83